Improving survival rates for adolescents and young adults (AYAs) with cancer
Globally, the incidence of sarcoma in young adults is approximately 2/100,000 persons with a greater incidence in males over females by a 2:1 ratio. Previous radiation and chemotherapy exposure before the age of 20, as well as exposure to certain chemical agents, has been linked to an increased risk in the development of sarcoma in the young adult population. Young adult sarcoma patients seem to do worse then their pediatric counterparts for a variety of reasons, one being the differences in the biology of their cancers. These differences in biology need to be accounted for when establishing treatment plans in this age group in determining pediatric- versus adult-based protocols.
Source: Soliman H, Ferrari A, Thomas D. Sarcoma in the Young Adult Population: An International View. Semin Oncol. 2009; 36:227-236.
Related Articles
Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: A study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Eur J Cancer. 2012 Sep 10;
Authors: Kasper B, Ouali M, van Glabbeke M, Blay JY, Bramwell VH, Woll PJ,...
Related Articles
Length of stay and treatment-related complications are similar in pediatric and AYA patients with bone sarcoma in United States children's hospitals.
Pediatr Blood Cancer. 2012 Jun 15;
Authors: Audino AN, Yeager ND, Asti L, Miao Y, O'Brien SH
Abstract
BACKGROUND: Adolescent and...
Related Articles
Impact of cancer on work and education among adolescent and young adult cancer survivors.
J Clin Oncol. 2012 Jul 1;30(19):2393-400
Authors: Parsons HM, Harlan LC, Lynch CF, Hamilton AS, Wu XC, Kato I, Schwartz SM, Smith AW, Keel G, Keegan TH
Abstract
...
Related Articles
Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study.
J Cancer Surviv. 2012 Mar 29;
Authors: Keegan TH, Lichtensztajn DY, Kato I, Kent EE, Wu XC, West MM, Hamilton AS, Zebrack B, Bellizzi KM, Smith AW, and the AYA HOPE Study...
Related Articles
Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007.
BMC Cancer. 2012;12:151
Authors: Haggar FA, Preen DB, Pereira G, Holman CDj, Einarsdottir K
Abstract
UNLABELLED: ABSTRACT:
BACKGROUND: Increasing incidence and...
Related Articles
Positive and negative psychosocial impact of being diagnosed with cancer as an adolescent or young adult.
Cancer. 2012 Mar 13;
Authors: Bellizzi KM, Smith A, Schmidt S, Keegan TH, Zebrack B, Lynch CF, Deapen D, Shnorhavorian M, Tompkins BJ, Simon M, and the Adolescent and Young Adult Health Outcomes and...
Related Articles
Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference?
J Clin Oncol. 2011 Oct 20;29(30):4045-53
Authors: Parsons HM, Harlan LC, Seibel NL, Stevens JL, Keegan TH
Abstract...
Related Articles
Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: the road ahead.
Crit Rev Oncol Hematol. 2012 Jun;82(3):259-79
Authors: Van Gaal JC, De Bont ES, Kaal SE, Versleijen-Jonkers Y, van der Graaf WT
Abstract
...
Related Articles
Sodium butyrate (SB) augments the effects of 1,25 dihydroxyvitamin D3 (1,25(OH)2D3) on neoplastic and osteoblastic phenotype in clonal rat osteosarcoma cells.
Biochem Biophys Res Commun. 1984 Jun 29;121(3):796-801
Authors: Yoneda T, Aya S, Sakuda M
Abstract
1,25 Dihydroxyvitamin D3 suppressed colony formation in soft agar and...
Related Articles
[Chromosome and DNA analyses of peripheral blood lymphocyte from the quadruple cancer patient].
Gan To Kagaku Ryoho. 1992 Jul;19(7):1055-7
Authors: Yamaguchi H, Kaneda K, Aya T, Imai S, Yamawaki S, Moriuchi T
Abstract
The patient with quadruple cancer was a 32 year-old female who had osteosarcoma, bilateral breast cancer and...
Related Articles
Overview of sarcomas in the adolescent and young adult population.
J Pediatr Hematol Oncol. 2005 Apr;27(4):215-8
Authors: Herzog CE
Abstract
Based on the data of the...
Related Articles
Adolescent and young adult (AYA) oncology: the first A.
Pediatr Hematol Oncol. 2007 Jul-Aug;24(5):325-36
Authors: Bleyer A
Abstract
Whereas adolescents with cancer as a group used to have a better prognosis than children with malignant disease, trends...
from patients, caregivers and medical professionals dealing with this disease and many other diseases
Share This Tip